U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.

Development of gene expression signatures with lncRNAs for 64 T-ALL patient samples

(Submitter supplied) Genetic studies in T-cell acute lymphoblastic leukemia have uncovered a remarkable complexity of oncogenic and loss-of-function mutations. Amongst this plethora of genetic changes, NOTCH1 activating mutations stand out as the most frequently occurring genetic defect, identified in more than 50% of T-cell acute lymphoblastic leukemias, supporting an essential driver role for this gene in T-cell acute lymphoblastic leukemia oncogenesis. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL19197
64 Samples
Download data: TXT
Series
Accession:
GSE61866
ID:
200061866
2.

The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by array; Expression profiling by high throughput sequencing
Platforms:
GPL11154 GPL19197
144 Samples
Download data: TXT
Series
Accession:
GSE62006
ID:
200062006
3.

RNA-sequencing of CD34+ thymocytes that were cultured on an OP9-GFP or OP9-DLL1 feeder layer.

(Submitter supplied) Genetic studies in T-cell acute lymphoblastic leukemia have uncovered a remarkable complexity of oncogenic and loss-of-function mutations. Amongst this plethora of genetic changes, NOTCH1 activating mutations stand out as the most frequently occurring genetic defect, identified in more than 50% of T-cell acute lymphoblastic leukemias, supporting an essential driver role for this gene in T-cell acute lymphoblastic leukemia oncogenesis. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL11154
4 Samples
Download data: TSV
4.

RNA-sequencing of the GSI treatment of the CUTLL1 cell line

(Submitter supplied) Genetic studies in T-cell acute lymphoblastic leukemia have uncovered a remarkable complexity of oncogenic and loss-of-function mutations. Amongst this plethora of genetic changes, NOTCH1 activating mutations stand out as the most frequently occurring genetic defect, identified in more than 50% of T-cell acute lymphoblastic leukemias, supporting an essential driver role for this gene in T-cell acute lymphoblastic leukemia oncogenesis. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL11154
12 Samples
Download data: TSV
5.

Development of gene expression signatures with lncRNAs for T-cell subsets (CD34+ and CD4+CD8+)

(Submitter supplied) Genetic studies in T-cell acute lymphoblastic leukemia have uncovered a remarkable complexity of oncogenic and loss-of-function mutations. Amongst this plethora of genetic changes, NOTCH1 activating mutations stand out as the most frequently occurring genetic defect, identified in more than 50% of T-cell acute lymphoblastic leukemias, supporting an essential driver role for this gene in T-cell acute lymphoblastic leukemia oncogenesis. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL19197
13 Samples
Download data: TXT
Series
Accession:
GSE61873
ID:
200061873
6.

Development of gene expression signatures with lncRNAs for coculture of CD34+ T-cells with an OP9-DLL1 feeder layer

(Submitter supplied) Genetic studies in T-cell acute lymphoblastic leukemia have uncovered a remarkable complexity of oncogenic and loss-of-function mutations. Amongst this plethora of genetic changes, NOTCH1 activating mutations stand out as the most frequently occurring genetic defect, identified in more than 50% of T-cell acute lymphoblastic leukemias, supporting an essential driver role for this gene in T-cell acute lymphoblastic leukemia oncogenesis. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL19197
8 Samples
Download data: TXT
Series
Accession:
GSE61871
ID:
200061871
7.

Development of gene expression signatures with lncRNAs for GSI treatment of T-ALL cell lines

(Submitter supplied) Genetic studies in T-cell acute lymphoblastic leukemia have uncovered a remarkable complexity of oncogenic and loss-of-function mutations. Amongst this plethora of genetic changes, NOTCH1 activating mutations stand out as the most frequently occurring genetic defect, identified in more than 50% of T-cell acute lymphoblastic leukemias, supporting an essential driver role for this gene in T-cell acute lymphoblastic leukemia oncogenesis. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL19197
16 Samples
Download data: TXT
Series
Accession:
GSE61870
ID:
200061870
8.

Development of gene expression signatures with lncRNAs for GSI treatment of the CUTLL1 cell line.

(Submitter supplied) Genetic studies in T-cell acute lymphoblastic leukemia have uncovered a remarkable complexity of oncogenic and loss-of-function mutations. Amongst this plethora of genetic changes, NOTCH1 activating mutations stand out as the most frequently occurring genetic defect, identified in more than 50% of T-cell acute lymphoblastic leukemias, supporting an essential driver role for this gene in T-cell acute lymphoblastic leukemia oncogenesis. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL19197
12 Samples
Download data: TXT
Series
Accession:
GSE61869
ID:
200061869
9.

Development of gene expression signatures with lncRNAs for 15 T-ALL patients

(Submitter supplied) Genetic studies in T-cell acute lymphoblastic leukemia have uncovered a remarkable complexity of oncogenic and loss-of-function mutations. Amongst this plethora of genetic changes, NOTCH1 activating mutations stand out as the most frequently occurring genetic defect, identified in more than 50% of T-cell acute lymphoblastic leukemias, supporting an essential driver role for this gene in T-cell acute lymphoblastic leukemia oncogenesis. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL19197
15 Samples
Download data: TXT
Series
Accession:
GSE61863
ID:
200061863
10.

Transcriptome profiling in human T-ALL

(Submitter supplied) Genome-wide mapping and characterization of novel Notch-regulated long non-coding RNAs in acute leukemia
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL11154
31 Samples
Download data: TXT
11.

Characterization of B- and T-lineage ALL by Integrated Analysis of microRNA and mRNA Expression Profiles

(Submitter supplied) Acute lymphoblastic leukemia (ALL) is an heterogeneous disease comprising several subentities that differ for both immunophenotypic and molecular characteristics. Over the years, the biologic understanding of this neoplasm has largely increased. Gene expression profiling has recently allowed to identify specific signatures for the different ALL subsets and permitted identification of pathways deregulated by a given lesion. more...
Organism:
Homo sapiens
Type:
Expression profiling by array; Non-coding RNA profiling by array
Platforms:
GPL570 GPL8191
39 Samples
Download data: CEL, XLS
Series
Accession:
GSE14834
ID:
200014834
12.

Genome-wide chromatin maps of T-cell acute lymphoblastic leukemia (T-ALL)

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by array; Genome binding/occupancy profiling by high throughput sequencing
Platforms:
GPL570 GPL11154
36 Samples
Download data: BW, CEL
Series
Accession:
GSE54380
ID:
200054380
13.

Genome-wide chromatin maps of T-cell acute lymphoblastic leukemia (T-ALL) [ChIP-seq]

(Submitter supplied) Here we modeled T-ALL resistance to Notch inhibition, identifying ‘persister’ cells that readily expand in the presence of gamma secretase inhibitor (GSI) and the absence of Notch signaling. Rare persister cells are already present in naïve T-ALL populations, and the reversibility of the phenotype is suggestive of an epigenetic mechanism. Relative to GSI-sensitive cells, persisters activate distinct signaling and gene expression programs, and exhibit global chromatin compaction. more...
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL11154
28 Samples
Download data: BW
Series
Accession:
GSE54379
ID:
200054379
14.

Gene expression profiles of T-cell acute lymphoblastic leukemia cell lines with and without chronic GSI-treatment

(Submitter supplied) Here we modeled T-ALL resistance to Notch inhibition, identifying ‘persister’ cells that readily expand in the presence of gamma secretase inhibitor (GSI) and the absence of Notch signaling. Rare persister cells are already present in naïve T-ALL populations, and the reversibility of the phenotype is suggestive of an epigenetic mechanism. Relative to GSI-sensitive cells, persisters activate distinct signaling and gene expression programs, and exhibit global chromatin compaction. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
8 Samples
Download data: CEL
Series
Accession:
GSE54378
ID:
200054378
15.

Ikaros deficient mouse thymic lymphomas

(Submitter supplied) This dataset comprises expression profiles from 3 thymic lymphomas from Ikaros deficient mice (IkL/L model, see Dumortier et al, Mol. Cell. Biol. 26, 209-220, 2006 for a description of the tumor model) and 3 thymic lymphomas from IkL/L mice that harbor a mutation of the Notch1 gene (deletion of floxed sequences comprising the promoter and exon 1 with the CD4-Cre transgene). The results from this experimpent is that the expression of Notch target genes was unexpectedly not altered in the tumors with the Notch1 deletion. more...
Organism:
Mus musculus
Type:
Expression profiling by array
Dataset:
GDS4174
Platform:
GPL1261
6 Samples
Download data: CEL
Series
Accession:
GSE23972
ID:
200023972
16.
Full record GDS4174

Notch1 promoter deletion effect on Ikaros-deficient model of T-cell acute lymphoblastic leukemia: thymic lymphoma

Analysis of thymic tumors from Ikaros-deficient (IkL/L) mice with a Notch promoter/exon1 deletion. The deletion of Notch1 promoter results in oncogenic activation of Notch1 and significantly accelerates leukemogenesis. Results provide insight into role of Notch activation in pathogenesis of T-ALL.
Organism:
Mus musculus
Type:
Expression profiling by array, count, 2 age, 2 genotype/variation sets
Platform:
GPL1261
Series:
GSE23972
6 Samples
Download data: CEL
17.

SCL and LMO1 reprogram thymocytes into self-renewing cells.

(Submitter supplied) The SCL and LMO1 oncogenic transcription factors reprogram thymocytes into self-renewing pre-leukemic stem cells (pre-LSCs). Here we report that SCL directly interacts with LMO1 to activate the transcription of a self-renewal program coordinated by LYL1.
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL339
6 Samples
Download data: CEL
Series
Accession:
GSE74659
ID:
200074659
18.

Oncogenesis of T-ALL and non-malignant consequences of overexpressing NOTCH1

(Submitter supplied) We have determined the consequences of ICN1 overexpression from retroviral vectors introduced into bone marrow cells. Even though the tumors consist of phenotypically heterogeneous cells, no evidence for tumor stem cells was found.
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL1261
9 Samples
Download data: CEL, CHP
Series
Accession:
GSE12948
ID:
200012948
19.

Synergistic antileukemic therapies in NOTCH-induced T-ALL

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL10558
66 Samples
Download data
Series
Accession:
GSE78189
ID:
200078189
20.

Gene expression profiling of CUTLL cell lines upon 17 drug treatments

(Submitter supplied) The clinical development of targeted therapies has been hampered by their limited intrinsic antitumor activity and the rapid emergence of resistance, highlighting the need to identify highly active and synergistic drug combinations. However, empirical synergistic drug screening approaches are challenging and elucidating the mechanisms that underlie such drug interactions is typically complex. Here we performed an expression based screen and network analyses to identify drugs amplyfiying the antitumor effects of NOTCH inhibition in T-ALL. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL10558
54 Samples
Download data: TXT
Series
Accession:
GSE78188
ID:
200078188
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=3|blobid=MCID_6759dbe845907c47ca0e36b1|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center